Princeton is building a new building for their chemistry department. The money for the construction is coming largely from Alimta, the cancer drug. Princeton holds the patent on pemetrexed, which was developed there by Edward Taylor.
The Food and Drug Administration just approved zolinza for treatment of a rare form of skin cancer called cutaneous T-cell lymphoma (CTCL). In addition to CTCL, Zolinza is being investigated in other indications including myeloma, mesothelioma and a variety of other cancers that have entered phase I and II clinical trials since June 2005. It’s always good to hear about new cancer medications that scientists are working on.
